Severe tricuspid valve (TV) regurgitation (TR) has been associated with adverse long-term outcomes in several natural history studies, but isolated TV surgery presents high mortality and morbidity rates. Transcatheter tricuspid valve interventions (TTVI) therefore represent a promising field and may currently be considered in patients with severe secondary TR that have a prohibitive surgical risk. Tricuspid transcatheter edge-to-edge repair (T-TEER) represents one of the most frequently used TTVI options. Accurate imaging of the tricuspid valve (TV) apparatus is crucial for T-TEER preprocedural planning, in order to select the right candidates, and is also fundamental for intraprocedural guidance and post-procedural follow-up. Although transesophageal echocardiography represents the main imaging modality, we describe the utility and additional value of other imaging modalities such as cardiac CT and MRI, intracardiac echocardiography, fluoroscopy, and fusion imaging to assist T-TEER. Developments in the field of 3D printing, computational models, and artificial intelligence hold great promise in improving the assessment and management of patients with valvular heart disease.
Background: The Ejection Fraction (EF) represents a fundamental pillar for the phenotypic classification and clinical management of cardiovascular diseases. Although trans-thoracic echocardiography (TTE) acts as the first-line examination and cardiac magnetic resonance (CMR) is the reference gold standard, cardiac computed tomography (CCT) has undergone a technological evolution. The advent of wide-detector scanners and artificial intelligence (AI) models has enabled CCT to transition from a purely morphological tool to a modality capable of comprehensive, three-dimensional morpho-functional assessments. Methods: This narrative review evaluates the literature across Scopus, MEDLINE, and Web of Science regarding the calculation of biventricular function and EF using CCT. It provides an updated summary of current clinical applications, technological advancements, and comparative diagnostic reliability against TTE and CMR. Results: The CCT “one-stop-shop” concept allows for the simultaneous acquisition of anatomical data and systolic function metrics (EDV, ESV, SV, EF), optimizing clinical workflows at no additional cost. Being intrinsically three-dimensional, CCT bypasses the geometric assumptions and apical foreshortening artifacts typical of 2D-TTE, demonstrating high volumetric concordance with CMR. Nevertheless, structural limitations persist, primarily regarding ionizing radiation exposure, contrast media toxicity, dependence on heart rhythm stability, and lower temporal resolution compared to CMR. Conclusions: EF determination via CCT has achieved technical maturity and clinical validation. While it does not intend to replace TTE or CMR, it offers synergistic data when integrated with primary anatomical indications. Furthermore, AI integration has been shown to potentially automate this workflow, transforming CCT into an opportunistic screening tool for subclinical cardiac dysfunction.
Testicular dislocation in the abdomen after scrotal trauma is a rare and sometimes unrecognised event. Early detection and timely management reduce possible complications which include the risk of fertility loss, endocrine dysfunction, and future malignancy. We present the case of a man who suffered a traumatic dislocation of the right testis in the abdomen after a motorcycle crash. The large scrotal haematoma did not permit adequate physical examination. Furthermore, during the clinical management of the polytrauma, the main focus was on active arterial bleeding, multiple pelvic fractures and clinical investigation of the integrity of the lower urinary tract. Therefore, the diagnosis and surgical management of the testicular dislocation were delayed. The patient underwent abdominal-inguinal surgical exploration, haematoma evacuation, identification of the right testis and right orchidopexy. After 6 months, the right testis of the patient is of regular volume, consistency and physiologic echogenicity on ultrasound evaluation. Hormonal evaluation and semen analysis were normal after 3 months.
Background: Right heart failure (HF) and tricuspid regurgitation (TR) are closely interrelated conditions, linked by a bidirectional and self-perpetuating pathophysiological relationship. Alterations in right-ventricular (RV) loading conditions, pulmonary vascular impedance, and ventriculo-arterial (VA) coupling play a central role in the development and progression of TR, which in turn exacerbates RV volume overload and end-organ dysfunction. Methods: This review provides a comprehensive overview of the pathophysiology of right HF and TR, focusing on the mechanisms underlying RV dysfunction, pressure–volume (PV) relationships, and pulmonary vascular load. We further examine the clinical implications of this interaction and summarize current strategies for risk stratification, with particular emphasis on disease-specific risk models. Results: TR emerges both as a consequence and a driver of RHF. Conditions such as pulmonary hypertension (PH) and left-sided heart disease promote annular dilation and leaflet tethering, leading to functional TR. Conversely, TR increases RV volume overload, worsening chamber dilation, reducing effective forward stroke volume (SV), and accelerating disease progression. This vicious cycle results in progressive RV impairment, impaired left-ventricular filling through ventricular interdependence, and systemic venous congestion affecting renal and hepatic function. Traditional risk scores fail to capture this complex pathophysiology. In this context, TRISCORE integrates clinical, biological, and echocardiographic (TTE) parameters reflecting RV dysfunction and systemic involvement, providing a more comprehensive assessment of disease severity and prognosis. Conclusions: TR should be considered not only a marker but also a key determinant of right HF progression. A multiparametric approach integrating pathophysiology and disease-specific risk stratification is essential to identifying the optimal therapeutic window and guiding clinical decision making.
Scope: The main purpose of our study was to collect computed tomography (CT) measurements of fat parameters that are significantly related to body mass index (BMI) and evaluate the associations of these measurements and sarcopenia with early and long-term complications after transcatheter aortic valve implantation (TAVI) in order to investigate the existence of the so-called ‘obesity paradox’ and the role of sarcopenia in this phenomenon. Materials and Methods: We analyzed the significance of fat CT measurements in 85 patients undergoing the TAVI procedure and compared these with each other, as well as with quantified CT BMI and fat density measurements. Secondly, we evaluated the associations of BMI, CT measurements of fat, and CT evaluations of skeletal muscle mass with early and long-term complications after 24 months of post-TAVI follow-up. Results: We found positive and significant relationships between fat CT measurements with each other and with BMI and a negative and significant relation between fat density and fat quantity. By comparing the CT measurements of fat and skeletal muscle mass with early and long-term complications after TAVI, we confirmed the existence of the ‘obesity paradox’ and the poor effect of sarcopenia after the TAVI procedure. Conclusions: We confirm that overweight and obesity are good prognostic factors, and sarcopenia is a poor prognostic factor for outcomes following the TAVI procedure. We focused on the scientific validation of an easy and fast way to measure fat and skeletal muscle mass using CT to better predict the outcomes of patients undergoing TAVI.